Chemours (CC) Equity Income (2014 - 2026)

Chemours' Equity Income history runs 13 years deep, the most recent figure standing at $8.0 million for Q1 2026.

• In Q1 2026, Equity Income changed 0.0% year-over-year to $8.0 million; the TTM figure through Mar 2026 stood at $34.0 million (down 12.82% YoY), while the FY2025 annual figure was $35.0 million, down 18.6% from the prior year.
• Equity Income was $8.0 million for Q1 2026 at Chemours, roughly flat from $8.0 million in the prior quarter.
• In the past five years, Equity Income ranged from a high of $16.0 million in Q2 2022 to a low of $7.0 million in Q4 2023.
• Historically, Equity Income has averaged $10.9 million across 5 years, with a median of $11.0 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Equity Income surged 60.0% in 2022, then slumped 38.46% in 2025.
• A 5-year view of Equity Income shows it stood at $11.0 million in 2022, then slumped by 36.36% to $7.0 million in 2023, then advanced by 28.57% to $9.0 million in 2024, then decreased by 11.11% to $8.0 million in 2025, then changed by 0.0% to $8.0 million in 2026.
• The last three Equity Income figures came in at $8.0 million (Q1 2026), $8.0 million (Q4 2025), and $9.0 million (Q3 2025), per Business Quant data.